Andén, N E <br/><br/>
Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.  [electronic resource] 

 -  The Journal of pharmacy and pharmacology  Mar 1972 
 - 177-82 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3573 
<br/><br/><label>Standard No.: </label>10.1111/j.2042-7158.1972.tb08961.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzimidazoles--pharmacology<br/>Brain--metabolism<br/>Chlorpromazine--pharmacology<br/>Dibenzothiazepines--pharmacology<br/>Dopamine--metabolism<br/>Dopamine beta-Hydroxylase--antagonists & inhibitors<br/>Haloperidol--pharmacology<br/>Male<br/>Methyltyrosines--pharmacology<br/>Mixed Function Oxygenases--antagonists & inhibitors<br/>Neurons--metabolism<br/>Norepinephrine--metabolism<br/>Rats<br/>Spinal Cord--metabolism<br/>Spiro Compounds--pharmacology<br/>Thiocarbamates--pharmacology<br/>Tranquilizing Agents--pharmacology<br/>Tyrosine 3-Monooxygenase--antagonists & inhibitors